睿智医药 (300149.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(睿智医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 253,361,151.72230,569,838.29234,594,741.64292,187,394.32288,723,816.62288,795,947.15268,658,644.91
 营业收入(元) 253,361,151.72230,569,838.29234,594,741.64292,187,394.32288,723,816.62288,795,947.15268,658,644.91
二、营业总成本(元) 249,114,023.28261,639,016.01263,463,408.41318,699,483.59304,777,325.46274,673,480.31300,284,445.11
 营业成本(元) 191,057,362.48196,198,202.90193,136,476.58207,265,158.11217,098,551.07226,480,433.19192,281,330.81
 研发费用(元) 13,108,752.0815,265,205.6016,901,112.2518,615,935.4121,533,998.4316,367,554.1620,950,769.76
 营业税金及附加(元) 940,696.212,166,121.46970,462.102,575,686.49314,532.602,502,993.78276,531.67
 销售费用(元) 7,251,273.5910,083,482.3110,997,471.4211,966,928.5111,925,879.2711,516,244.5510,187,537.94
 管理费用(元) 30,356,100.7838,472,669.9439,205,533.2669,690,371.3448,808,851.4134,047,220.7860,003,484.81
 财务费用(元) 6,399,838.14-546,666.202,252,352.808,585,403.735,095,512.68-16,240,966.1516,584,790.12
  其中:利息费用(元) 771,580.401,078,001.911,061,819.9027,013,075.65905,092.34771,669.402,609,317.74
  其中:利息收入(元) 2,503,265.212,385,905.332,278,712.703,387,044.672,742,897.011,595,016.867,068,700.94
 资产减值损失(元) -10,245,301.49-1,446,135.71-1,936,377.65-875,025,272.07-53,079.43-1,268,321.42-1,523,226.08
 信用减值损失(元) -2,879,486.42-12,149,318.96272,295.47-4,722,007.591,737,691.99-2,645,662.60-443,594.50
三、其他经营收益
 加:公允价值变动收益(元) -----115,732.67--
 加:投资收益(元) 4,801,000.62773,602.981,727,374.35-11,186,555.552,033,221.414,949,982.513,280,955.00
  其中:对联营企业和合营企业的投资收益(元) 4,718,008.42635,931.371,719,000.61-11,232,825.691,941,407.484,652,438.713,107,725.19
 资产处置收益(元) 3,573,654.91--1,545,605.72-1,532,431.36--
 其他收益(元) 3,615,869.721,439,185.051,536,809.633,979,479.381,013,351.911,675,490.711,903,168.29
四、营业利润(元) 3,114,514.34-42,403,710.39-27,268,564.97-911,555,890.12-12,970,486.9916,571,152.70-28,408,497.49
 加:营业外收入(元) 8,963.23-47,831.2667,985.42496,831.6995,011.07102,190.01121,847.23
 减:营业外支出(元) 104,734.55165,772.50239,553.364,152,474.855,246.2560,060.00317.30
五、利润总额(元) 3,018,743.02-42,617,314.15-27,440,132.91-915,211,533.28-12,880,722.1716,613,282.71-28,286,967.56
 减:所得税费用(元) 1,820,890.41-5,136,862.93-1,940,382.03-29,741,166.643,422,833.356,604,534.27-3,113,174.84
六、净利润(元) 1,197,852.61-37,480,451.22-25,499,750.88-885,470,366.64-16,303,555.5210,008,748.44-25,173,792.72
(一)按经营持续性分类
  持续经营净利润(元) 1,197,852.61-37,480,451.22-25,499,750.88-885,470,366.64-16,303,555.5210,008,748.44-25,173,792.72
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 1,239,484.38-37,445,942.08-25,460,550.66-885,429,752.91-16,227,230.1710,049,422.48-25,145,108.24
  少数股东损益(元) -41,631.77-34,509.14-39,200.22-40,613.73-76,325.35-40,674.04-28,684.48
 扣除非经常性损益后的净利润(元) -5,002,682.97-36,029,196.58-28,009,409.29-880,548,007.44-16,572,416.067,047,435.30-29,246,265.24
七、每股收益
 一、基本每股收益(元) 0.01-0.08-0.05-1.78-0.030.02-0.05
 二、稀释每股收益(元) 0.01-0.08-0.05-1.78-0.030.02-0.05
八、其他综合收益(元) -8,289,139.80-3,020,740.511,875,939.70-2,178,590.92216,038.3815,200,286.38-5,414,466.45
 归属于母公司股东的其他综合收益(元) -8,289,139.80-3,020,740.511,875,939.70-2,178,590.92216,038.3815,200,286.38-5,414,466.45
九、综合收益总额(元) -7,091,287.19-40,501,191.73-23,623,811.18-887,648,957.56-16,087,517.1425,209,034.82-30,588,259.17
 归属于母公司所有者的综合收益总额(元) -7,049,655.42-40,466,682.59-23,584,610.96-887,608,343.83-16,011,191.7925,249,708.86-30,559,574.69
 归属于少数股东的综合收益总额(元) -41,631.77-34,509.14-39,200.22-40,613.73-76,325.35-40,674.04-28,684.48
公告日期 2024-10-302024-08-302024-04-262024-04-262023-10-252023-08-292023-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院